Advisor Pro Platform— 510(k) K210561

Substantially Equivalent

DreaMed Diabetes, Ltd.

FDA 510(k) clearance K210561 for Advisor Pro Platform, Substantially Equivalent on 2021-09-28. Applicant: DreaMed Diabetes, Ltd..

Clearance details

Applicant: DreaMed Diabetes, Ltd.
Product code: Code QCC
Advisory panel: Clinical Chemistry
Date received: 2021-02-25
Decision date: 2021-09-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Petah Tikva, IL

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.